Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefanie Schenk

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Deutsches Arzteblatt International|April 4, 2015
Questionable pooling of dataStefanie Schenk
Deutsches Arzteblatt International|July 7, 2009
Reduction in cervical cancers proven?Stefanie Schenk
Lancet (London, England)|March 28, 2003
The COOPERATE trialJutta Halbekath, Stefanie Schenk
Lancet (London, England)|October 13, 2009
HPV vaccination in women aged 24-45 yearsStefanie Schenk, Jutta Halbekath
Archives of Internal Medicine|March 14, 2007
Risedronate for the prevention of hip fractures: concern about validity of trialsJutta Martha Halbekath, Stefanie Schenk, Andreas von Maxen, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Deutsches Arzteblatt International|April 4, 2015
Questionable pooling of dataStefanie Schenk
Deutsches Arzteblatt International|July 7, 2009
Reduction in cervical cancers proven?Stefanie Schenk
Lancet (London, England)|March 28, 2003
The COOPERATE trialJutta Halbekath, Stefanie Schenk
Lancet (London, England)|October 13, 2009
HPV vaccination in women aged 24-45 yearsStefanie Schenk, Jutta Halbekath
Archives of Internal Medicine|March 14, 2007
Risedronate for the prevention of hip fractures: concern about validity of trialsJutta Martha Halbekath, Stefanie Schenk, Andreas von Maxen, et al.
Pageof 1